The present invention relates to medicine and veterinary, namely, to immunology, and to methods aimed at correcting the immune system of a living organism. The essence of the invention is in the immunocorrection of the organism using pharmacologically appropriate amino derivatives of 2,3-dihydrophthalazine-1,4˜dione in their effective doses ranging from 0.2 &mgr;g to 1,000 mg.
本发明涉及医学和兽医学,即免疫学,以及旨在纠正
生物体免疫系统的方法。本发明的精髓在于使用药理上适当的 2,3-二氢
酞嗪-1,4˜二酮的
氨基衍
生物对
生物体进行免疫矫正,其有效剂量从 0.2 毫克到 1,000 毫克不等。